Serum from some seropositive (RF +) rheumatoid arthritis (RA) 
Introduction
Previous reports document the occurrence of polyclonal, low molecular weight IgM (7S, IgM) in various patients with autoimmune diseases (1) (2) (3) (4) (5) (6) (7) (8) and occasionally in apparently normal individuals (9, 10) . In rheumatoid arthritis (RA)' patients, seropositive for rheumatoid factor (RF+), the occurrence of 7S IgM is associated with disease severity and frequently with vasculitis, (11, 12) . In immunodiffusion studies using specific antiIgM antibodies reacting with 19S or 7S IgM the characteristics of 7S IgM appear identical to those of pentameric 19S IgM (4, 13, 14) . These studies failed to identify unique determinants on 7S IgM as opposed to the 19S species (14) . Antinuclear reactivity of 7S IgM, derived from lupus erythematosus patients has previously been described (1, 3) . In addition, some 7S IgM molecules from RA patients show low efficiency binding to aggregated human immunoglobulin by a double antibody binding radioimmunoassay (14) .
In the present study, we report the presence of the major rheumatoid, crossreactive idiotype (RCRI) among 7S IgM molecules obtained from the sera of the three RF+ RA patients, as defined by the prototypic monoclonal 19S IgM molecules originally described by Kunkel (15, 16) . Utilizing indirect immunofluorescence (17) and hemagglutination inhibition assays (15, 16) , we observed that 7S IgM molecules obtained from RF+ patients' sera inhibit polyclonal anti-major RCRI antibodies from binding RCRI+ molecules in the cytoplasm of peripheral blood lymphocyte (PBL)-derived, pokeweed mitogen (PWM)-induced plasma cells from RA patients, or from reacting with prototypic reduced and alkylated 19S IgM RFs placed on the surface of sheep red blood cells (SRBC). The reaction of anti-RCRI antibodies with RCRI' monoclonal IgM RF was not inhibited in either assay by seronegative (RF-) 7S IgM obtained from one "RA" patient, or by reduced and alkylated polyclonal normal IgM. These observations imply that RA 7S IgM include molecules that belong to the major RCRI group and therefore are closely related to their 19S IgM, RF counterparts.
Methods
Human cells. Nine active rheumatoid arthritis patients with high titer RF, measured by IgG-coated latex particle agglutination, were studied for the production of RCRI in PWM cultures. The serological data of these patients, as well as that of seven normal volunteers used as controls, are given in Table I .
Production, screening, andpreparation ofanti-RCRI antibodies. Anti-RCRI antibodies raised in Flanders Giant rabbits were obtained as previously described in detail (17, 18) . In short, Ea monoclonal pentameric IgM (RF+, member of the major RCRI group) was injected subcutaneously in complete Freund's adjuvant into rabbits. Sequential postimmunization bleedings were performed and the anti-RCRI activity assayed as previously described (17) . Aliquots of sera were tested with two members of the major RCRI group (Ea, Wa) by hemagglutination inhibition after subjecting the anti-RCRI antibodies to exhaustive absorption on solid phase, Sepharose coupled immunoabsorbents, including cord serum, pooled polyclonal IgG, and four monoclonal IgM, kappa, RF-immunoglobulins (17, 18 Preparation of anti-human F(ab')2, and anti-rabbit IgG antibodies conjugated with tetramethyl rhodamine isothiocyanate (TRITC) orfluorescein isothiocyanate (FITC). Goat antisera to human IgM were absorbed on a Sepharose coupled column of human IgG. The eluted, affinity purified anti-human F(ab')2 antibodies, were then directly conjugated with TRITC as described (17) . All anti-human immunoglobulin reagents were absorbed with Sepharose coupled rabbit IgG before use in indirect fluorescence double staining. In addition, a sheep anti-rabbit IgG reagent was prepared and directly conjugated with FITC (17) , to stain indirectly, the RCRI' plasma cells that bound rabbit anti-RCRI antibodies. Preparation ofPWM-induced plasma cellsfrom rheumatoid patients and normal PBL donors. Heparinized peripheral blood was obtained from RA patients and normal volunteers and separated on Ficoll-Hypaque density gradients to obtain PBL. Cells were further prepared for tissue culture as described previously (17) . In short, I X 106 PBL were incubated with PWM for 6 d at 370C, 5% CO2 air atmosphere in RPMI 1640 with 10% fetal bovine serum (FBS), and harvested at day 6. PWMinduced plasma cells were made ready for immunofluorescent staining by preparing cytocentrifuge slides and fixing these mounted cells in acid alcohol (5% glacial acetic acid, 95% ethanol) for 30 min 0C followed by two washes in ice-cold phosphate-buffered saline (PBS) 0.01 M, pH 7.2.
Staining ofplasma cells. Plasma cells were stained by indirect immunofluorescence assay with rabbit anti-RCRI antibodies, 150 ,g/ml, 20 Ml per slide, followed by sheep anti-rabbit IgG-FITC as described (17) .
After exhaustive washing in PBS, all slides were counter stained, to enumerate total number of plasma cells, with goat anti-human F(ab')2-TRITC, washed again and then mounted in polyvinyl alcohol before counting. In all patients and control individuals studied, 100 plasma cells were counted on each of two or more separate slides. These data reflect a total of 2 200 PWM-induced plasma cells counted in each experimental condition described and RCRI' plasma cells are expressed as the percentage, i.e., RCRI' plasma cells oftotal PWM-induced plasma cells counted.
Waaler-Rose hemagglutination assayfor rheumatoidfactor activity. Washed SRBC were coupled with purified human IgG by the chromium chloride (CrC13) method as previously described (19) . Aliquots of sera, 20 Mul in each well were diluted 212 (1:4,096) , in PBS 0.01 M, pH 7.2, with 1% FBS, (preabsorbed with SRBC), before adding the human IgGcoated SRBC.
Latexfixation by rheumatoid sera. Latex particles coated with purified human IgG (Hyland Laboratories, Costa Mesa, CA) were used to measure the RF IgG binding titer of the various patient and control sera as previously described (20) . Detection ofmonomeric 7S IgMfrom rheumatoid patients' sera. A solution of 4% acrylamide was poured in small petri dishes, allowed to polymerize for 20 min and then prepared for immunodiffusion in two directions with an Ouchterlony template hole punch. A goat antiserum, specific for human u-chains, was added to the center well and patient's sera added to the surrounding wells as described (4) . Low molecular weight 7S.IgM, as opposed to 19S IgM, was specifically identified in rheumatoid sera by the exclusion capacity of 4% polyacrylamide gel matrix for the 19S species.
Preparation of low molecular weight 7S from rheumatoid patients' sera. Four different polyclonal monomeric IgM reagents were prepared after their initial identification. 20-ml aliquots ofserum from each patient Ty, Ha, Sin (RF+ sera), and Ho, (RF-serum), were made 40% vol/vol with a saturated (NH4)2SO4 solution. The resulting precipitate was solubilized and dialyzed into borate saline pH 8.0. The mixture of immunoglobulins was separated by AcA 34 (LKB, Bromma, Sweden) molecular weight chromatography into 19S and 7S species. The 7S peak was pooled, concentrated and then applied to a Sepharose-coupled rabbit anti-human g-affinity chromatography column. The affinity pure 7S IgM species was eluted by 0.05 M glycine HO pH 2.8 and then neutralized to pH 8.0, concentrated, and tested for purity in Ouchterlony agar gel diffusion for reactivity with anti-M-or anti-gamma specific goat antisera.
None of the eluted 7S IgM species reacted with anti-gamma antibodies (14) . All species were anti-human M-reactive. 7% polyacrylamide gel electrophoresis was performed to check the molecular weight ofall species of 7S IgM recovered (14) .
Reduction and alkylation of19SIgM obtainedfrom Ea, (monoclonal IgM), and control sera (polyclonal IgM). Reduction and alkylation of monoclonal IgM from patient Ea, (member of the major RCRI group, immunogen for the polyclonal anti-RCRI antibodies) and polyclonal IgM obtained from control sera was performed as described previously (21) . IgM preparations were reduced by dialysis against 0.1 M mercaptoethanol (Eastman Kodak Co., Rochester, NY) in sodium phosphate buffer 0.2 M, pH 7.5. Dissociated samples were alkylated to prevent spontaneous reassociation by dialysis against large volumes of 0.2 M monoiodoacetamide (K and K Laboratories, Plainview; NY) prepared in the same buffer. The reduced and alkylated samples were finally dialyzed against 0.15 M NaCI and run on 7% polyacrylamide gels to determine molecular weight.
In addition, aliquots of Ea and control polyclonal I9S IgM, were reduced by dialysis against 0.02 M cysteine HCO in 0.2 M Tris, pH 8.6 for 22 h at 22°C, as described (14), to prevent intrasubunit disulfide bond disruption that might change the antigenic tertiary structure of these IgM molecules and prevent anti-RCRI antibody antigen binding.
Alkylation of cysteine HC1 reduced IgM molecules was performed as described above.
Absorption ofanti-RCRI antibody by low molecular weight 7S IgM. Aliquots of anti-RCRI antibodies absorbed with 12% normal human serum were further absorbed with 7S IgM. 20 ,d ofanti-RCRI antibodies at 150 ;g/ml were mixed with 20 Ml of7S IgM at 300 ,g/ml and incubated 30 min at 4°C and then spun 9,000 g for 2 min at 25°C. The resulting supernatant was used to stain PWM-induced plasma cells from patients or controls. Aliquots of anti-RCRI antibodies were also absorbed with reduced and alkylated 19S IgM from control sera. After incubation, these absorbed anti-RCRI antibodies were used in parallel experiments to stain PWM-induced plasma cells as previously stated (16, 17) .
Hemagglutination inhibition ofanti-RCRI antibodies reacting with monomeric IgM coated SRBC by 7S 1gM obtained from rheumatoid patients. Washed SRBC were coupled with monomeric IgM, Ty, Sin, and reduced and alkylated Ea with various concentrations of CrC13 as described (19) . 50 Ml of anti-human F(ab')2 antibodies at a concentration of 1 mg/ml were serially diluted 212 (1:4, (Table II) . These RCRI+ plasma cells were stained equally well in the presence or absence of low molecular weight IgM. These findings were also seen in all seven controls (Table III) (Table IV) . In both cases, neither 7S IgM from RF-RA patient Ho or reduced and alkylated normal 19S 1gM inhibited hemagglutination of Ty coated SRBC by anti-RCRI antibodies. Seven S IgM from patient Sin, on the surface of SRBC was also recognized by anti-RCRI antibodies. This reaction was blocked by the addition of 7S Ea IgM, Table IV. In these experiments 50 ,ul ofrabbit IgG (RIgG), at a concentration of 300 Mg/ml agglutinated Ty or Sin coated SRBC at a titer of 2, 4, and 2, respectively. (Table  V) . Neither 7S IgM from RF-RA patient Ho or reduced and alkylated normal 7S IgM inhibited specific hemagglutination by anti-RCRI antibodies. Again, 50 MlI of RIgG at a concentration of 300 ,g/ml failed to agglutinate 7S Ea or Sin coated SRBC at a titer > 2. Normal 7S IgM coated SRBC were not agglutinated by anti-RCRI antibodies. These SRBC were well coated with IgM as shown by agglutination with anti-human F(ab')2 antibodies (Table V) .
Discussion
The presence of 7S, IgM in sera obtained from patients with RA, is associated with disease severity, articular, and extraarticular manifestations of RA, and is indicative of rheumatoid vasculitis (1 1, 12) . Although, 7S, IgM may therefore be viewed as a serologic marker for RA activity, its pathophysiologic role in the disease process remains unclear (14) . 7S IgM has been shown to bind complement in an anti-I, complement mediated hemolysis assay (22) and complement binding aggregate assay (14) . In addition some 7S IgM molecules can form soluble immune complexes with aggregated IgG (14) and react with DNA (1, 3) . The major RF, RCRI, originally described by Kunkel (15, 16) defines a set of monoclonal 19S, IgM RF by their shared idiotopes (18) independent of their IgG, Fc binding potential. This major RCRI includes 60% ofall monoclonal 19S, IgM RFs as defined by polyclonal anti-major RCRI antibodies. Polyclonal anti-RCRI antibodies identify RFs and related molecules free of the problems found in low affinity for "antigen" interactions characteristic of RFs in the classic IgG, Fc binding assays (23, 24) . Typical association constants for IgM or IgG, RFs average between 1 X 104, 5 X 105 L/M (23, 24) , which is 10-to 100-fold less than the affinities ofheteroantibodies produced following exogenous immunization. In addition, we (17) and others (25) , have observed the major RCRI in high frequency in RA both at the cellular and serologic level employing polyclonal antimajor RCRI antibodies (17, 18) .
Utilizing the immunofluorescence RCRI system, two populations of RCRI expressing plasma cells in RF+ RA patients are clearly seen (Table II) (Table II, III) . Ke and Ge may express the Po, minor crossreactive idiotype, as originally described by Kunkel (15, 16) , or private RF idiotypes with unique, unshared idiotopes in preference to the major RCRI.
By preabsorption of anti-RCRI antibodies with 7S, IgM before indirect immunofluorescence (Table II) , the plasma cells reacting with anti-major RCRI are divided into two subpopulations, one 7S IgM absorbable and the other resistant to absorption. 7S IgM from three different RF+ RA patients absorbed 30-83% ofthe anti-RCRI binding activity toward RCRI+ plasma cells in six of the seven RF+ RA "high" RCRI expressor patients, and had no effect on two other RF+ RA patient or control cells. The remaining "background," RCRI+ plasma cells may represent immunoglobulin molecules produced by a set of separate non-RF related B-cell clones that share some determinants with the 7S, IgM obtained from an RF-"RA" patient (Ho), and reduced and alkylated normal polyclonal IgM, both failed to absorb any activity of specific anti-RCRI antibodies (Table II) . These observations in conjunction with those seen in hemagglutination inhibition assay (Tables IV and V) Finally, 7S, IgM appear to be independent biosynthetic IgM molecules and not degradation products of pentameric IgM (3, 5, 14, 26) . Except for its low molecular weight as compared to the pentamer, and the difference in binding avidity for the Fc portion ofIgG, 7S, IgM molecules are similar to their 19S counterparts (3-6, 13). Our observations idiotypically link 7S, IgM with 19S, IgM RFs both monoclonal and polyclonal, and are consistent with those observations in which weak IgG, Fc binding activity by some 7S, IgM species was noted (14) . Idiotypic determination of RF anti-immunoglobulins by the polyclonal anti-RCRI system circumvents "antigen" binding problems encountered in 7S IgM, RF assays (14) and easily demonstrates their association with RF.
